There is currently limited high-quality human safety data on DSIP peptide use
Our cutting-edge therapies, including peptide therapy, stem cell therapy, and PRP (Platelet-Rich Plasma) therapy, are designed to treat shoulder injuries, rotator cuff injuries, and shoulder pain
Dermal Models: Wound-closure, skin integrity, cellular migration, and tissue-remodeling research
Eligibility required a body mass index (BMI) of 30 kg/m or higher, or for those with at least one obesity-related comorbidity and no diabetes, a BMI of 27 kg/m or higher
Large-scale data consistently show cardiovascular drugs (statins and blood-pressure medications), diabetes drugs, thyroid replacement, antidepressants/anxiolytics, asthma/sinus treatments, pain relievers, and antibiotics among the most-prescribed